細胞冷凍保存市場規模、佔有率和成長分析（按產品、應用、最終用途和地區）- 產業預測 2025-2032

2023 年細胞冷凍保存市場規模價值 88 億美元，預計將從 2024 年的 107.8 億美元成長到 2032 年的 546.6 億美元，預測期內（2025-2032 年）的複合年成長率為 22.5%。

細胞冷凍保存因其能夠在極低的溫度下保持細胞懸浮狀態，有效地保持細胞活力並防止結晶形成而受到廣泛歡迎。該技術對於保存用於基礎研究和醫學應用的生物材料（包括幹細胞和活組織）至關重要。傳統的冷凍方法常常因膜損傷或滲透壓衝擊而導致細胞死亡，因此冷凍保存對於長期儲存至關重要。冷凍保護劑和溫度控制技術的最新進展顯著提高了冷凍保存的成功率。此外，對冷凍保存的細胞和組織進行廣泛的品質測試可以評估它們是否適合移植，從而無需新鮮樣本，並增加了研究和治療的機會。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析

細胞冷凍保存市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 細胞冷凍培養基
  • 乙二醇
  • 二甲基亞碸
  • 甘油
  • 其他
• 裝置
  • 冷凍庫
  • 培養箱
  • 液態氮供應罐
• 耗材
  • 低溫管瓶
  • 低溫管
  • 冷藏箱/容器
  • 其他

細胞冷凍保存市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概況
• 幹細胞
• 卵子和生殖細胞
• 精子細胞
• 肝細胞
• 其他

細胞冷凍保存市場規模（依最終用途和複合年成長率） (2025-2032)

• 市場概況
• 生物製藥和製藥公司
• 研究組織
• 生物庫
• 試管嬰兒診所
• 其他

細胞冷凍保存市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Thermo Fisher Scientific（US）
• Merck KGaA（Germany）
• GE Healthcare（US）
• BioLife Solutions, Inc.（US）
• Cook Medical（US）
• FUJIFILM Irvine Scientific（US）
• Lonza（Switzerland）
• Sartorius AG（Germany）
• Cytiva（US）
• Corning Incorporated（US）
• STEMCELL Technologies Inc.（Canada）
• PromoCell GmbH（Germany）
• Bio-Techne Corporation（US）
• HiMedia Laboratories Pvt. Ltd.（India）
• Miltenyi Biotec（Germany）
• Takara Bio Inc.（Japan）
• ReproCELL Inc.（Japan）
• Core Dynamics, LLC（US）
• Chart Industries, Inc.（US）
• Worthington Industries（US）

結論和建議

Cell Cryopreservation Market size was valued at USD 8.8 billion in 2023 and is poised to grow from USD 10.78 billion in 2024 to USD 54.66 billion by 2032, growing at a CAGR of 22.5% during the forecast period (2025-2032).

Cell cryopreservation is gaining traction for its ability to maintain cells in a suspended state at cryogenic temperatures, effectively preserving their viability while preventing ice crystal formation. This technique is essential for preserving biological materials, including stem cells and viable tissues, used in both basic research and medical applications. Traditional freezing methods often lead to cell death due to membrane damage and osmotic shock, making cryopreservation vital for long-term storage. Recent advancements in cryoprotective agents and temperature control technologies have significantly improved the success rates of cryopreservation. Furthermore, extensive quality testing of cryopreserved cells and tissues allows for their suitability assessment for transplantation, eliminating the need for fresh samples and enhancing research and therapeutic opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Cryopreservation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Cryopreservation Market Segments Analysis

Global Cell Cryopreservation Market is segmented by Product, Application, End Use and region. Based on Product, the market is segmented into Cell Freezing Media, Equipment and Consumables. Based on Application, the market is segmented into Stem Cells, Oocytes and Embryotic cells, Sperm Cells, Hepatocytes and Others. Based on End Use, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, Research Institutes, Biobanks, IVF clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cell Cryopreservation Market

The global cell cryopreservation market is projected to experience significant growth driven by the escalating prevalence of chronic diseases and the emergence of novel viruses. This trend is further propelled by the heightened research and development efforts in stem cell science, as scientists and clinicians delve deeper into this field. Educational institutions worldwide are offering grants to PhD students, Clinical Research Fellows, and postdoctoral researchers, thereby fostering advancements in stem cell research. Additionally, various government initiatives aimed at promoting research activities within the pharmaceutical and biopharmaceutical sectors are also contributing to the market's expansion, highlighting the increasing importance of cell preservation technologies.

Restraints in the Cell Cryopreservation Market

The cell cryopreservation market faces significant restraints due to the presence of alternative therapies and the substantial costs associated with storage solutions. As various treatment options gain popularity, the demand for traditional cryopreservation methods may be impacted negatively. Additionally, the high expenses involved in maintaining and operating storage facilities for cryopreserved cells further hinder market growth. These financial burdens can deter new entrants and existing businesses from expanding their offerings, ultimately limiting the potential expansion of the cell cryopreservation market in the face of competing technologies and solutions that provide similar benefits at potentially reduced costs.

Market Trends of the Cell Cryopreservation Market

The cell cryopreservation market is increasingly favoring vitrification as a dominant preservation technique, driven by advancements in cryobiology and cell storage technologies. This method leverages fast freezing using high concentrations of cryoprotectants, significantly reducing ice formation and cellular damage compared to traditional slow cooling processes. While vitrification enhances cell viability and recovery rates, concerns about potential toxicity from concentrated cryoprotectants highlight the need for ongoing research and optimization. As the demand for cell-based therapies and regenerative medicine rises, the market is witnessing innovation and investment focused on improving vitrification techniques to enhance safety and efficacy in cryopreservation applications.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Cell Cryopreservation Market Size by Product & CAGR (2025-2032)

• Market Overview
• Cell Freezing Media
  • Ethylene Glycol
  • Dimethyl Sulfoxide
  • Glycerol
  • Others
• Equipment
  • Freezers
  • Incubators
  • Liquid Nitrogen Supply Tanks
• Consumables
  • Cryogenic vials
  • Cryogenic tubes
  • Cooler boxes/containers
  • Others

Global Cell Cryopreservation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Stem Cells
• Oocytes and Embryotic cells
• Sperm Cells
• Hepatocytes
• Others

Global Cell Cryopreservation Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Biopharmaceutical & Pharmaceutical Companies
• Research Institutes
• Biobanks
• IVF clinics
• Others

Global Cell Cryopreservation Market Size & CAGR (2025-2032)

• North America (Product, Application, End Use)
  • US
  • Canada
• Europe (Product, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLife Solutions, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Irvine Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiMedia Laboratories Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReproCELL Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Core Dynamics, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chart Industries, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Worthington Industries (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations